Old Web
English
Sign In
Acemap
>
Paper
>
3-year follow-up from a randomized phase 3 trial (DASISION) Early response with dasatinib or imatinib in chronic myeloid leukemia:
3-year follow-up from a randomized phase 3 trial (DASISION) Early response with dasatinib or imatinib in chronic myeloid leukemia:
2014
Andreas Hochhaus
Dong-Wook Kim
M. Brigid Bradley-Garelik
Hesham Mohamed
Mark Wildgust
Charles Chuah
Carolina Pavlovsky
Jiri Mayer
Jorge Cortes
Hagop M. Kantarjian
Giuseppe Saglio
Juan Luis Steegmann
Neil P. Shah
Keywords:
Cancer research
Myeloid leukemia
Imatinib
Dasatinib
Medicine
Oncology
Internal medicine
Correction
Cite
Save
Machine Reading By IdeaReader
19
References
1
Citations
NaN
KQI
[]